NCT02684812View on ClinicalTrials.gov

Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

955

Participants

Timeline

Start Date

July 16, 2012

Primary Completion Date

July 29, 2019

Study Completion Date

November 1, 2020

Conditions
Subarachnoid Hemorrhage
Interventions
DRUG

Tranexamic Acid

Treatment until aneurysm treatment or maximum dosage of 4 gram

Trial Locations (1)

Unknown

Academic Medical Centre, Amsterdam

All Listed Sponsors
collaborator

Stichting Nuts Ohra

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT02684812 - Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage. | Biotech Hunter | Biotech Hunter